| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd5537af900106df1a2e4d63470098e3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-207
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-173
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-173
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-207 |
| filingDate |
2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b40346394bc01b868e2455d92326d31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ca6108ba88cec382710e7db3792e73c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f4bed309e6f08b1ad4c4266224125cb |
| publicationDate |
2020-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-036409-B1 |
| titleOfInvention |
PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTI-CANCER AGENTS |
| abstract |
The present invention relates to cladribine derivatives of formula (II). The compounds are phosphoramidate derivatives in which the phosphoramidate moiety is located at the 3'-hydroxyl group of cladribine. The present invention also relates to pharmaceutical formulations of cladribine derivatives. The compounds are useful in the treatment of cancer. |
| priorityDate |
2016-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |